Total Payments
$5,589
2024 Payments
$123.60
Companies
38
Transactions
181
Medicare Patients
4,530
Medicare Billing
$671,642
Payment Breakdown by Category
Food & Beverage$4,011 (71.8%)
Travel$1,562 (28.0%)
Education$15.56 (0.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,011 | 177 | 71.8% |
| Travel and Lodging | $1,562 | 3 | 28.0% |
| Education | $15.56 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Nuvectra Corporation | $2,221 | 10 | $0 (2018) |
| Scilex Pharmaceuticals Inc. | $314.42 | 21 | $0 (2023) |
| Nevro Corp. | $294.24 | 3 | $0 (2020) |
| Collegium Pharmaceutical, Inc. | $292.36 | 18 | $0 (2024) |
| Medtronic USA, Inc. | $233.93 | 7 | $0 (2020) |
| Abbott Laboratories | $225.21 | 9 | $0 (2022) |
| Nalu Medical, Inc. | $198.71 | 6 | $0 (2024) |
| Bioventus LLC | $155.53 | 10 | $0 (2020) |
| Flexion Therapeutics, Inc. | $153.70 | 9 | $0 (2020) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $135.92 | 9 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $123.60 | 6 | Nalu Medical, Inc. ($58.67) |
| 2023 | $167.58 | 9 | Collegium Pharmaceutical, Inc. ($74.60) |
| 2022 | $465.11 | 20 | SPR Therapeutics, Inc ($87.53) |
| 2021 | $307.98 | 15 | Nalu Medical, Inc. ($73.55) |
| 2020 | $741.14 | 29 | Nevro Corp. ($247.50) |
| 2019 | $572.17 | 38 | Scilex Pharmaceuticals Inc. ($117.91) |
| 2018 | $2,559 | 41 | Nuvectra Corporation ($2,029) |
| 2017 | $652.71 | 23 | Nuvectra Corporation ($192.24) |
All Payment Transactions
181 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Nalu Medical, Inc. | Nalu Neurostimulation System (Device) | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: Pain Management | ||||||
| 10/12/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $14.08 | General |
| Category: Opioid Analgesic | ||||||
| 04/26/2024 | Nalu Medical, Inc. | Nalu Neurostimulation System (Device) | Food and Beverage | In-kind items and services | $35.12 | General |
| Category: Pain Management | ||||||
| 04/03/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $18.36 | General |
| Category: Opioid Analgesic | ||||||
| 02/27/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $18.12 | General |
| Category: Opioid Analgesic | ||||||
| 02/02/2024 | Forte Bio-Pharma LLC | NALOCET (Drug), PROLATE, PROLATE | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: PAIN | ||||||
| 10/30/2023 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $24.07 | General |
| Category: Opioid Analgesic | ||||||
| 08/10/2023 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $17.71 | General |
| Category: Opioid Analgesic | ||||||
| 07/26/2023 | Forte Bio-Pharma LLC | NALOCET (Drug), PROLATE, PROLATE | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: PAIN | ||||||
| 06/29/2023 | Forte Bio-Pharma LLC | NALOCET (Drug), PROLATE, PROLATE | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: PAIN | ||||||
| 06/13/2023 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $16.52 | General |
| Category: Opioid Analgesic | ||||||
| 05/31/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: Gastroenterology | ||||||
| 03/28/2023 | Scilex Pharmaceuticals Inc. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: Analgesic | ||||||
| 02/08/2023 | Scilex Pharmaceuticals Inc. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: Analgesic | ||||||
| 01/27/2023 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $16.30 | General |
| Category: Opioid Analgesic | ||||||
| 12/31/2022 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $87.53 | General |
| Category: Pain management | ||||||
| 11/16/2022 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $15.34 | General |
| Category: Opioid Analgesic | ||||||
| 09/15/2022 | Horizon Therapeutics plc | PENNSAID (Drug) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: PENNSAID | ||||||
| 09/06/2022 | Scilex Pharmaceuticals Inc. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: Analgesic | ||||||
| 08/11/2022 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $44.82 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 08/09/2022 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $17.11 | General |
| Category: Opioid Analgesic | ||||||
| 07/29/2022 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: Neuromodulation | ||||||
| 07/20/2022 | Scilex Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $11.73 | General |
| 06/21/2022 | Scilex Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $12.71 | General |
| 06/09/2022 | Nalu Medical, Inc. | Nalu Neurostimulation System (Device) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: Pain Management | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 1,067 | 4,245 | $621,467 | $186,796 |
| 2022 | 29 | 1,345 | 5,582 | $734,263 | $208,162 |
| 2021 | 25 | 1,197 | 4,425 | $559,320 | $156,078 |
| 2020 | 23 | 921 | 3,710 | $455,574 | $120,606 |
Total Patients
4,530
Total Services
17,962
Medicare Billing
$671,642
Procedure Codes
103
All Medicare Procedures & Services
103 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 120 | 169 | $87,880 | $40,547 | 46.1% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 54 | 66 | $89,628 | $29,097 | 32.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 143 | 219 | $78,621 | $18,755 | 23.9% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 53 | 72 | $39,888 | $16,263 | 40.8% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 49 | 82 | $46,002 | $14,597 | 31.7% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 48 | 64 | $33,472 | $8,298 | 24.8% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 45 | 75 | $21,450 | $7,133 | 33.3% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2023 | 34 | 39 | $31,005 | $6,795 | 21.9% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Office | 2023 | 23 | 42 | $26,082 | $6,028 | 23.1% |
| 64624 | Destruction of nerve branches of knee using imaging guidance | Office | 2023 | 13 | 19 | $21,660 | $5,323 | 24.6% |
| 64633 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 11 | 14 | $19,222 | $5,242 | 27.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 37 | 38 | $20,900 | $4,121 | 19.7% |
| 64634 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 11 | 16 | $9,760 | $3,426 | 35.1% |
| 64491 | Injection of upper or middle spine facet joint using imaging guidance, second level | Office | 2023 | 23 | 42 | $13,104 | $3,240 | 24.7% |
| 64454 | Injection of anesthetic agent and/or steroid into knee nerve branch using imaging guidance | Office | 2023 | 15 | 15 | $9,000 | $2,814 | 31.3% |
| 96130 | Evaluation of psychological test, first hour | Office | 2023 | 15 | 29 | $8,497 | $2,424 | 28.5% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 12 | 13 | $9,269 | $2,322 | 25.0% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 28 | 30 | $4,050 | $1,827 | 45.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 26 | 27 | $6,561 | $1,803 | 27.5% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 16 | 22 | $6,587 | $1,723 | 26.2% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2023 | 18 | 18 | $5,400 | $1,361 | 25.2% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 26 | 30 | $6,090 | $1,167 | 19.2% |
| 99426 | Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 16 | 31 | $4,619 | $1,142 | 24.7% |
| G0396 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | Office | 2023 | 15 | 28 | $4,900 | $679.38 | 13.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 94 | 519 | $5,190 | $421.89 | 8.1% |
About Dr. Keley Booth, MD
Dr. Keley Booth, MD is a Anesthesiology healthcare provider based in Oklahoma City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1558387696.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Keley Booth, MD has received a total of $5,589 in payments from pharmaceutical and medical device companies, with $123.60 received in 2024. These payments were reported across 181 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($4,011).
As a Medicare-enrolled provider, Booth has provided services to 4,530 Medicare beneficiaries, totaling 17,962 services with total Medicare billing of $671,642. Data is available for 4 years (2020–2023), covering 103 distinct procedure/service records.
Ad
Practice Information
- Specialty Anesthesiology
- Location Oklahoma City, OK
- Active Since 07/14/2006
- Last Updated 12/07/2015
- Taxonomy Code 207L00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1558387696
Products in Payments
- Algovita (Device) $2,221
- Senza Spinal Cord Stimulation System (Device) $294.24
- Nalu Neurostimulation System (Device) $198.71
- Belbuca (Drug) $185.25
- Zilretta (Drug) $172.47
- ZTLido (Drug) $142.38
- ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH (Drug) $130.20
- GELSYN 3 (Device) $122.58
- XTAMPZA (Drug) $107.11
- Proclaim Family of SCS IPGs (Device) $102.76
- RESTORE (Device) $98.60
- INTELLIS (Device) $95.99
- Puraply (Medical Supply) $93.29
- iFuse Implant (Device) $92.37
- RELISTOR (Drug) $89.87
- SPRINT PNS System (Device) $87.53
- FORTEO (Drug) $78.36
- PROCLAIM (Device) $64.31
- BELBUCA (Drug) $62.31
- Qutenza (Drug) $58.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anesthesiology Doctors in Oklahoma City
Garrett Wright, Md, MD
Anesthesiology — Payments: $116,888
Anesthesiology $116,888
Emily Pollard, M.d, M.D
Anesthesiology — Payments: $106,496
Anesthesiology $106,496
Kenichi Tanaka, M.d, M.D
Anesthesiology — Payments: $96,569
Anesthesiology $96,569
Aly El Banayosy, Md, MD
Anesthesiology — Payments: $66,112
Anesthesiology $66,112
Dr. John Nelson, Md, MD
Anesthesiology — Payments: $35,798
Anesthesiology $35,798
Dr. Justin Porter, M.d, M.D
Anesthesiology — Payments: $11,989
Anesthesiology $11,989